169 related articles for article (PubMed ID: 16116173)
1. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation.
Yuan R; El-Asady R; Liu K; Wang D; Drachenberg CB; Hadley GA
J Immunol; 2005 Sep; 175(5):2868-79. PubMed ID: 16116173
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
[TBL] [Abstract][Full Text] [Related]
3. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection.
Hadley GA; Charandee C; Weir MR; Wang D; Bartlett ST; Drachenberg CB
Transplantation; 2001 Nov; 72(9):1548-55. PubMed ID: 11707744
[TBL] [Abstract][Full Text] [Related]
4. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells.
Feng Y; Wang D; Yuan R; Parker CM; Farber DL; Hadley GA
J Exp Med; 2002 Oct; 196(7):877-86. PubMed ID: 12370250
[TBL] [Abstract][Full Text] [Related]
5. Tubulitis after renal transplantation: demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade.
Robertson H; Wong WK; Talbot D; Burt AD; Kirby JA
Transplantation; 2001 Jan; 71(2):306-13. PubMed ID: 11213078
[TBL] [Abstract][Full Text] [Related]
6. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
[TBL] [Abstract][Full Text] [Related]
7. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
[TBL] [Abstract][Full Text] [Related]
8. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
[TBL] [Abstract][Full Text] [Related]
9. Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B.
Einecke G; Fairhead T; Hidalgo LG; Sis B; Turner P; Zhu LF; Bleackley RC; Hadley GA; Famulski KS; Halloran PF
Am J Transplant; 2006 Sep; 6(9):2109-20. PubMed ID: 16869802
[TBL] [Abstract][Full Text] [Related]
10. CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.
Liu K; Anthony BA; Yearsly MM; Hamadani M; Gaughan A; Wang JJ; Devine SM; Hadley GA
PLoS One; 2011; 6(7):e21968. PubMed ID: 21779359
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes.
Hadley GA; Rostapshova EA; Gomolka DM; Taylor BM; Bartlett ST; Drachenberg CI; Weir MR
Transplantation; 1999 Jun; 67(11):1418-25. PubMed ID: 10385079
[TBL] [Abstract][Full Text] [Related]
12. Application of anti-CD103 immunotoxin for saving islet allograft in context of transplantation.
Zhang L; Hadley GA
Chin Med J (Engl); 2010 Dec; 123(24):3644-51. PubMed ID: 22166645
[TBL] [Abstract][Full Text] [Related]
13. Negative immunohistochemical detection of CD103 (alphaEbeta7 integrin) in the infiltrates of acute rejection in liver and kidney transplantation.
Leteurtre E; Copin MC; Labalette M; Noel C; Roumilhac D; Pruvot FR; Lecomte-Houcke M; Gosselin B; Dessaint JP
Transplantation; 2000 Jul; 70(1):227-9. PubMed ID: 10919610
[TBL] [Abstract][Full Text] [Related]
14. Role of integrin CD103 in promoting destruction of renal allografts by CD8 T cells.
Hadley G
Am J Transplant; 2004 Jul; 4(7):1026-32. PubMed ID: 15196058
[TBL] [Abstract][Full Text] [Related]
15. Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells.
Al-Hamidi A; Pekalski M; Robertson H; Ali S; Kirby JA
Mol Immunol; 2008 Sep; 45(15):4000-7. PubMed ID: 18649941
[TBL] [Abstract][Full Text] [Related]
16. Efficient elimination of CD103-expressing cells by anti-CD103 antibody drug conjugates in immunocompetent mice.
Mang Y; Zhao Z; Zeng Z; Wu X; Li Z; Zhang L
Int Immunopharmacol; 2015 Jan; 24(1):119-27. PubMed ID: 25467246
[TBL] [Abstract][Full Text] [Related]
17. Rejection of kidney allografts by MHC class I-deficient mice.
Mannon RB; Nataraj C; Kotzin BL; Griffiths R; Geier S; Ibrahim S; Sanfilippo FP; Platt JL; Kurlander R; Coffman TM
Transplantation; 1995 Mar; 59(5):746-55. PubMed ID: 7886804
[TBL] [Abstract][Full Text] [Related]
18. Serine protease inhibitor-6 inhibits granzyme B-mediated injury of renal tubular cells and promotes renal allograft survival.
Lau A; Khan K; Pavlosky A; Yin Z; Huang X; Haig A; Liu W; Singh B; Zhang ZX; Jevnikar AM
Transplantation; 2014 Aug; 98(4):402-10. PubMed ID: 24918613
[TBL] [Abstract][Full Text] [Related]
19. Dominant tolerance to kidney allografts induced by anti-donor MHC class II antibodies: cooperation between T and non-T CD103+ cells.
Degauque N; Lair D; Dupont A; Moreau A; Roussey G; Moizant F; Hubert FX; Louvet C; Hill M; Haspot F; Josien R; Usal C; Vanhove B; Soulillou JP; Brouard S
J Immunol; 2006 Apr; 176(7):3915-22. PubMed ID: 16547225
[TBL] [Abstract][Full Text] [Related]
20. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.
Gaughan A; Wang J; Pelletier RP; Nadasdy T; Brodsky S; Roy S; Lodder M; Bobek D; Mofatt-Bruce S; Fairchild RL; Henry ML; Hadley GA
Am J Transplant; 2014 Feb; 14(2):284-94. PubMed ID: 24410909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
